Financial statements Pro-Pharma
Balance sheet of Pro-Pharma
Company age:
Age:
18 y. 9 m. 30 d.
Share capital:
Share capital:
100 000 PLN
Balance sheet data of PRO-PHARMA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 512 432,61 | 482 587,14 | 1 316 512,05 | 1 449 060,41 | 2 036 063,36 | 1 140 907,96 |
| A. Fixed assets | 0,00 | - | 0,00 | 0,00 | 1 151 250,00 | 298 750,00 |
| B. Current assets | 512 432,61 | 482 587,14 | 1 316 512,05 | 1 449 060,41 | 884 813,36 | 842 157,96 |
| C. Share capital contributions (basic funds) | 0,00 | - | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | - | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 512 432,61 | 482 587,14 | 1 316 512,05 | 1 449 060,41 | 2 036 063,36 | 1 140 907,96 |
| A. Equity | 89 346,80 | 141 344,02 | 118 487,95 | 178 315,85 | 235 538,03 | 319 758,73 |
| B. Liabilities and provisions for liabilities | 423 085,81 | 341 243,12 | 1 198 024,10 | 1 270 744,56 | 1 800 525,33 | 821 149,23 |
| I. Long-term liabilities | 0,00 | - | - | - | - | - |
| II. Short-term liabilities | 354 714,02 | - | - | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.